Skip to content
  • Global Key Solutions is now KeyPedia →
  • Independent Study of FDA Correspondence Finds Earliest CDER Warning Letter Citing AI Use →
  • KeyPedia Launches openFDA MCP Connector With an "Elsa for Industry" Approach →
  • KeyPedia Listed in TPRA’s TPRM Tools List →
  • Global Key Solutions is now KeyPedia →
  • Independent Study of FDA Correspondence Finds Earliest CDER Warning Letter Citing AI Use →
  • KeyPedia Launches openFDA MCP Connector With an "Elsa for Industry" Approach →
  • KeyPedia Listed in TPRA’s TPRM Tools List →
KeyPediaKeyPedia
  • Company
  • Platform
  • Media
  • KeyPedia Lite
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Emergent BioSolutions Canada Inc.
FDA Inspection•Emergent BioSolutions Canada Inc.•May 16, 2017

Emergent BioSolutions Canada Inc. – FDA Inspection, May 16, 2017

Record Details

This FDA Inspection record concerns Emergent BioSolutions Canada Inc., with an inspection on May 16, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
Emergent BioSolutions Canada Inc.
Inspection Date
May 16, 2017
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
People
  • Burnell M. Henry (FDA Associated Person)
  • Prabhu P. Raju (FDA Associated Person)

ID · e57724ff-639b-4a70-bc27-affc7bd9b34d

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1018375
FDA center
Biologics
Project area
Blood and Blood Products
Outcome
Form 483 issued

Other FDA inspections of Emergent BioSolutions Canada Inc.

8
DateClassificationOfficeProject area
May 12, 2026Not classifiedOffice of Inspections and InvestigationsBlood and Blood Products
August 27, 2025Not classifiedOffice of Inspections and Investigations
September 13, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 3, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 18, 2014VAICenter for Biologics Evaluation and ResearchBlood and Blood Products
View all 8 other inspections on the company page

Other documents for Emergent BioSolutions Canada Inc.

5
Document
FDA Inspection 1316698 · May 12, 2026 
FDA Inspection 1280431 · August 27, 2025 
FDA Inspection 1109095 · September 13, 2019 
FDA Inspection 918929 · February 3, 2015 
FDA Inspection 905505 · July 18, 2014 
View Company ProfileHave an account? Sign in to open in Dashboard

Or discuss it with

What you get

  1. A document

    One file.

    • One FDA document, such as a Form 483
    • Yours for life in your Library
    • Each has its own price
    here
  2. The profile

    All the documents, plus intelligence about the company.

    • Every Emergent BioSolutions Canada Inc. document on file
    • The KRA score, which a single document does not include
    • Observations and inspection history
  3. Access

    This, for every company on KeyPedia.

    • Combine profiles in one search
    • Search across any modality: products, industry types, drugs, devices and recalls
    • Track everything as it changes
    • Other agencies too, such as EMA, Health Canada and UK MHRA
    Browse free in KeyPedia Lite
KeyPedia
The intelligence layer for life sciences
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
Quick Links
HomePlatformUse CasesHardwarePricingResearchOur TechnologyFAQMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPrograms & Partnerships
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.